These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11053960)

  • 21. Electromyographic differences between normal upper and lower facial muscles and the influence of onabotulinum toxin a.
    Winn BJ; Sires BS
    JAMA Facial Plast Surg; 2013 May; 15(3):211-7. PubMed ID: 23430072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
    Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.
    Rollnik JD; Matzke M; Wohlfarth K; Dengler R; Bigalke H
    Eur Neurol; 2000; 43(1):9-12. PubMed ID: 10601802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report.
    Vazquez-Delgado E; Okeson JP
    Cranio; 2004 Oct; 22(4):325-9. PubMed ID: 15532318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
    Davidson BJ; Ludlow CL
    Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of distant effects of local injections of botulinum toxin.
    Garner CG; Straube A; Witt TN; Gasser T; Oertel WH
    Mov Disord; 1993; 8(1):33-7. PubMed ID: 8380486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum Toxin and Muscle Atrophy: A Wanted or Unwanted Effect.
    Durand PD; Couto RA; Isakov R; Yoo DB; Azizzadeh B; Guyuron B; Zins JE
    Aesthet Surg J; 2016 Apr; 36(4):482-7. PubMed ID: 26780946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia.
    Lee IH; Yoon YC; Sung DH; Kwon JW; Jung JY
    AJR Am J Roentgenol; 2009 Apr; 192(4):996-1001. PubMed ID: 19304706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia.
    Birkent H; Maronian N; Waugh P; Merati AL; Perkel D; Hillel AD
    Otolaryngol Head Neck Surg; 2009 Jan; 140(1):43-7. PubMed ID: 19130960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
    Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lateral pterygoid muscle dystonia. A new technique for treatment with botulinum toxin guided by electromyography and arthroscopy.
    Martos-Díaz P; Rodríguez-Campo FJ; Bances-del Castillo R; Altura-Guillén O; Cho-Lee GY; Mancha-de la-Plata M; Escorial-Hernandez V
    Med Oral Patol Oral Cir Bucal; 2011 Jan; 16(1):e96-9. PubMed ID: 20711164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia.
    Lu CS; Chen RS; Tsai CH
    J Formos Med Assoc; 1995 Apr; 94(4):189-92. PubMed ID: 7606182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum neurotoxin-A does not spread to distant muscles after intragastric injection: A double-blind single-fiber electromyography study.
    Osio M; Mailland E; Muscia F; Nascimbene C; Vanotti A; Bana C; Corsi F; Foschi D; Mariani C
    Muscle Nerve; 2010 Aug; 42(2):165-9. PubMed ID: 20564593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia.
    Gilio F; Currà A; Lorenzano C; Modugno N; Manfredi M; Berardelli A
    Ann Neurol; 2000 Jul; 48(1):20-6. PubMed ID: 10894212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes.
    Lange DJ; Rubin M; Greene PE; Kang UJ; Moskowitz CB; Brin MF; Lovelace RE; Fahn S
    Muscle Nerve; 1991 Jul; 14(7):672-5. PubMed ID: 1922173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical posttraumatic dystonia treated successfully by botulinum toxin injection.
    Lee SY; Lim JY
    Am J Phys Med Rehabil; 2015 Mar; 94(3):246-9. PubMed ID: 25415396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues.
    Young DL; Halstead LA
    J Voice; 2014 Sep; 28(5):614-7. PubMed ID: 24954039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.